OraSure Technologies, Inc.
(NASDAQ : OSUR)

( )
OSUR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.07%492.591.0%$790.42m
DHRDanaher Corp. 0.10%243.490.7%$637.27m
ABTAbbott Laboratories 0.34%124.800.8%$636.47m
MDTMedtronic Plc 0.03%126.030.6%$636.46m
ISRGIntuitive Surgical, Inc. 0.00%812.572.3%$365.61m
ALGNAlign Technology, Inc. 0.00%606.336.3%$353.61m
BDXBecton, Dickinson & Co. 0.07%261.121.0%$310.67m
SYKStryker Corp. -0.07%256.951.3%$300.39m
NVCRNovoCure Ltd. -0.78%191.006.8%$298.41m
DXCMDexCom, Inc. 0.00%400.047.8%$269.98m
BSXBoston Scientific Corp. 0.00%40.911.0%$259.36m
EWEdwards Lifesciences Corp. 0.07%89.080.4%$244.76m
IDXXIDEXX Laboratories, Inc. 0.00%535.003.7%$234.76m
BAXBaxter International, Inc. -0.05%86.521.8%$225.86m
AAgilent Technologies, Inc. -0.11%134.431.6%$216.62m

Company Profile

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.